Stockreport

Galecto to Participate in SVB Securities Global Biopharma Conference

Galecto, Inc.  (GLTO) 
PDF BOSTON, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company and a world leader in galectin biology focused on the de [Read more]